NCT06037187View on ClinicalTrials.gov

Coagulopathy of Immunodermatologic Diseases

RecruitingOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

May 9, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2025

Conditions
Autoimmune Bullous Dermatosis
Interventions
DIAGNOSTIC_TEST

Blood Draw

Standard coagulation assays (aPTT, INR, ACT), viscoelastic coagulation profiles (rotational thromboelastometry (ROTEM)/thromboelastography (TEG), tPA-challenged ROTEM/TEG), and molecular profiling

Trial Locations (1)

68198

RECRUITING

University of Nebraska Medical Center, Omaha

All Listed Sponsors
lead

University of Nebraska

OTHER